Loading ....
Contact us to order
Tel
+1 866.986.9598
Wuhan HealthCare Biotechnology Co., Ltd.
view supplier detailsCredit card payments now incur a 3% fee.
Wuhan HealthCare Biotechnology Co., Ltd.
view supplier detailsCredit card payments now incur a 3% fee.
| Mfr.No. | KL-AML01 | ||
| Gene Name | AML1/ETO | ||
| Fluorophore | Orange-Red/Green | ||
| Chromosome | 8, 21 | ||
| Description |  The ETO probe was labeled with orange-red dye, and the AML1 probe was labeled with green dye, and the two probes were combined to the target detection site by in situ hybridization. |
||
| Description | hematological tumor | ||
| Clinical Significance | The AML1/ETO gene fusion can be used as a secondary diagnosis of AML and a means of assessing prognosis. Clinically, t(8;21) leukemia represents a type of acute leukemia with good prognosis. Adult patients have good response to treatment, high complete remission rate, long median survival time, but easy recurrence; children's treatment and prognosis are not as good as adult patients. . | ||
| Disease | Acute Myeloid Leukemia /AML (Non APL) | ||
| Location | 8q21.3-22.1/21q22.11-22.12 | ||
| Image(s) |
|
